Pete Schmidt | CMO
Invivyd

Pete is the Chief Medical Officer of Invivyd.  He joined in November of 2020, first serving as the Vice President of Clinical Research before being appointed CMO in December of 2022. He brings nearly 15 years of experience in drug discovery to the team, having overseen both early and late-stage clinical development programs, as well as supporting key regulatory activities and filings. Prior to joining Invivyd, Pete worked in academic research and therapeutics development for neurology, pain, and respiratory products. He is an Assistant Clinical Professor in the Division of Pain Medicine at the Stanford University School of Medicine. He holds an M.D. from the University of Colorado School of Medicine, an M.S. in Epidemiology and Clinical Research from Stanford University, and a B.A. in Psychology from Cornell University.